At Investor Conferences

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 1748 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Iovance–Cellectis: gene editing technology, 202001– collab + license ww excl for TILs in several cancer indications 2020-01-12
Alderaan Biotechnology–Advent France Biotechnology: investment, 202001 financing round Series A totalling €18.5m incl existing investor AFB 2020-01-09
Alderaan Biotechnology–Medicxi: investment, 202001 financing round Series A totalling €18.5m incl new investor Medicxi 2020-01-09
Alderaan Biotechnology–SEVERAL: investment, 202001 financing round Series A €18.5m with Advent France Biotechnology + Medicxi 2020-01-09
Sanofi–Nurix Therapeutics: protein degradation drugs, 202001– collab strategic ww $55m upfront + $2.5m milestones using DELigase platform 2020-01-09
Riemser–Esteve: investment, 202001– acquisition €na of Riemser from Ardian by Esteve 2020-01-08
VectivBio–France (govt): investment, 202001 1st financing round totalling $35m incl Bpifrance + Inserm Transfer Initiative 2020-01-07
VectivBio–SEVERAL: investment, 202001 1st financing round $35m with Versant Ventures + Orbimed + Novo Holdings + Bpifrance et al. 2020-01-07
Pharma Omnium–Novo Group: investment, 202001 investment €7m by Novo REPAIR Impact fund into Mutabilis 2020-01-06
Augustine Therapeutics–SEVERAL: investment, 201912 seed financing round €4.2m from V-Bio Ventures + PMV + Advent France + Gemma Vrisius + VIB 2019-12-16
Aelis Farma–NewCap: public relations, 201912 service existent by NewCap 2019-12-13
Aelis Farma–SEVERAL: grant, 201912c research grants totalling €9m from various organisations incl US NIDA 2019-12-13
Aelis Farma–SEVERAL: investment, 201912 financing round €11m incl Region Nouvelle Aquitaine + Inserm Transfert Initiative + Bpifrance 2019-12-13
Inscripta–SEVERAL: investment, 201912 financing round Series D $125m led by Paladin Capital Group 2019-12-10
Synthorx–Sanofi: investment, 201912– acquisition $2.35b cash tender offer at $68/share ANNOUNCED 2019-12-09
ImCheck Therapeutics–Agent Capital: investment, 201912 financing round Series B totalling €48m incl new + co-investor Agent Capital 2019-12-04
ImCheck Therapeutics–Alexandria Real Estate: investment, 201912 financing round Series B totalling €48m incl new + co-investor Alexandria Venture 2019-12-04
ImCheck Therapeutics–Boehringer: investment, 201912 financing round Series B totalling €48m incl existing + co-investor BIVF 2019-12-04
ImCheck Therapeutics–Dechert: legal services, 201912 supply service Dechert LLP acted as legal counsel for €48m Series B round of ImCheck 2019-12-04
ImCheck Therapeutics–Dentons: legal services, 201912 supply service Dentons Europe acted as legal counsel for €48m Series B round of ImCheck 2019-12-04
ImCheck Therapeutics–France (govt): investment, 201912 financing round Series B totalling €48m incl co-lead investor Bpifrance InnoBio 2 + LV funds 2019-12-04
ImCheck Therapeutics–Gimv: investment, 201912 financing round Series B totalling €48m incl existing + co-investor Gimv 2019-12-04
ImCheck Therapeutics–Idinvest Partners: investment, 201912 financing round Series B totalling €48m incl existing + co-investor Idinvest Partners 2019-12-04
ImCheck Therapeutics–Kurma: investment, 201912 financing round Series B totalling €48m incl existing + co-investor Kurma Partners 2019-12-04
ImCheck Therapeutics–Life Sciences Partners: investment, 201912 financing round Series B totalling €48m incl existing + co-investor LSP 2019-12-04
ImCheck Therapeutics–Pfizer: investment, 201912 financing round Series B totalling €48m incl co-lead investor Pfizer Ventures 2019-12-04
ImCheck Therapeutics–SEVERAL: investment, 201912 financing round Series B €48m co-led by Bpifrance + Pfizer Ventures 2019-12-04
ImCheck Therapeutics–Trophic Communications: public relations, 201912 service existent IR + PR US + EU by Trophic 2019-12-04
ImCheck Therapeutics–Wellington Partners: investment, 201912 financing round Series B totalling €48m incl new + co-investor Wellington Partners 2019-12-04
Diabeloop–SEVERAL: investment, 201912 financing round Series B €22m led by Cemag Invest 2019-12-02
Innate Pharma–Rentschler: biologics contract manufacturing, –201912 supply service production lacutamab for clinical trials 2019-12-02
Sanofi–Ligand: transgenic animal technology, 201912– license ww for OmniAb platform 2019-12-02
ECBF–SEVERAL: investment, 201911– European Circular Bioeconomy Fund aims to raise €250m incl up to €100m from EIB 2019-11-29
Tissium–SEVERAL: investment, 201911 financing round Series B €38.75m from EIB + French investors 2019-11-20
Acticor Biotech–SEVERAL: investment, 201911 financing round Series B extension €7m led by new investorGO Capital bringing Series B to €22.3m 2019-11-06
AVCare–Acticor Biotech: investment, 201911 acquisition 100% of AVCare by Acticor Biotech 2019-11-06
Urania Therapeutics–Advent France Biotechnology: investment, 201911 seed financing round totalling €3.53m incl lead investor AFB 2019-11-06
Urania Therapeutics–Andrew Lloyd Associates: public relations, 201911 service existent by ALA 2019-11-06
Urania Therapeutics–Capital Grand Est: investment, 201911 seed financing round totalling €3.53m incl co-investor Cap Innov’Est 2019-11-06
Urania Therapeutics–Novalix: drug development services, 201911– supply of drug development services to Urania by Novalix 2019-11-06
Urania Therapeutics–SEVERAL: investment, 201911 seed financing round €3.53m led by Advent France Biotechnology + incl Cap Innov’Est 2019-11-06
BOOSTER Consortium–Acticor Biotech: glenzocimab, 201911– project partner with ph2 study of glenzocimab in combi with mechanical thrombectomy 2019-11-05
BOOSTER Consortium–France (govt): grant, 201911c– ANR RHU grant €9.9m for personalised management of stroke in emergency situations 2019-11-05
Poxel–IPF Partners: credit, 201911–201412 bond loan up to €30m in three tranches 11/19 + 3/20 + 12/21 2019-11-05
Pieris–SEVERAL: investment, 201911 private placement $32m w 9.015m units (shares + warrants) at $3.55/unit led by BVF Partners 2019-11-04
genOway–Institut Pasteur: transgenic anmials, 201910– license extension from IP + Cellectis to genOway to take legal actions against infringement 2019-10-30
Innate Pharma–SEVERAL: investment, 201910 pirvate placement €22.13m with 4.45m ordinary shares at €4.97/share 2019-10-21
Sofinnova–SEVERAL: investment, 201910 closing €333m of Sofinnova Capital IX fund 2019-10-17
Aeovian Pharmaceuticals–Apollo Ventures: investment, 201910 financing round Series A totalling $37m incl founding + co-investor Apollo Health Ventures 2019-10-03
Aeovian Pharmaceuticals–Evotec: investment, 201910 financing round Series A totalling $37m incl founding + co-investor Evotec 2019-10-03
Aeovian Pharmaceuticals–SEVERAL: investment, 201910 financing round Series A $37m led by VenBio + Sofinnova Investments 2019-10-03
Aeovian Pharmaceuticals–Sofinnova: investment, 201910 financing round Series A totalling $37m incl new + co-lead investor Sofinnova Investments 2019-10-03
Aeovian Pharmaceuticals–VenBio: investment, 201910 financing round Series A totalling $37m incl new + co-lead investor VenBio Partners 2019-10-03
Cellectis–Lonza: cell therapy contract manufacturing, 201910– supply UCART cell therapy candidates by Lonza in Geleen (NL) 2019-10-01
Tacalyx–SEVERAL: investment, 201909 seed financing round €7m co-led by BIVF + Kurma Partners 2019-09-25
Innate Pharma–SEVERAL: investment, 201909–201910 US IPO $54.5m with 9.922m ADSs at $5.5/ADS + listing of ADSs at Nasdaq Global Select Market 2019-09-20
Themis Bioscience–SEVERAL: investment, 201909 financing round Series D €40m co-led by Farallon Capital + Hadean Ventures 2019-09-18
Celyad–Ulysse Communication: public relations, 201909 service existent for Europe by Ulysse 2019-09-16
Inotrem–Andera Partners: investment, 201909 financing round Series B totalling €39m incl exisiting + co-investor Andera Partners 2019-09-12
Inotrem–BioMedPartners: investment, 201909 financing round Series B totalling €39m incl exisiting + co-investor BioMedInvest 2019-09-12
Inotrem–Invus Group: investment, 201909 financing round Series B totalling €39m incl co-investor Invus 2019-09-12
Inotrem–Morningside: investment, 201909 financing round Series B totalling €39m incl lead investor Morningside Ventures 2019-09-12
Inotrem–SEVERAL: investment, 201909 financing round Series B €39m led by Morningside Ventures 2019-09-12
Inotrem–Sofinnova: investment, 201909 financing round Series B totalling €39m incl exisiting + co-investor Sofinnova Partners 2019-09-12
Ermium Therapeutics–SEVERAL: investment, 201909 financing round Series A €6.3m from Domain Therapeutics + Kurma Partners + Idinvest + SATT Erganeo 2019-09-11
Keranova–SEVERAL: investment, 201909 2nd financing round €24m incl Mérieux Equity Partners + Supernova Invest + Arbevel + TI-invest 2019-09-10
Pharvaris–SEVERAL: investment, 201909 financing round Series B $66m led by Foresite Capital 2019-09-10
iStar Medical–SEVERAL: investment, 201905 financing round Series C €40m led by LSP + Gimv 2019-09-05
TreeFrog Therapeutics–EU (govt): grant, 201909– Horizon 2022 SME Instrument Program Phase 2 Grant €2.4m 2019-09-05
TreeFrog Therapeutics–France (govt): grant, 201909–2020 grant €450k from Bpifrance i-Nov Innovation Challenge Phase 2 2019-09-05
HiFiBio–Delian Capital: investment, 201908 financing round Series C totalling $67m incl new + co-investor Delian Capital 2019-08-28
HiFiBio–Gilead: investment, 201908 financing round Series C totalling $67m incl new + co-investor Kite 2019-08-28
HiFiBio–Hanne Capital: investment, 201908 financing round Series C totalling $67m incl new + co-investor Hanne Capital 2019-08-28
HiFiBio–IDG Capital: investment, 201908 financing round Series C totalling $67m incl new + lead investor IDG Capital 2019-08-28
HiFiBio–Legend Star Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Legend Star Capital 2019-08-28
HiFiBio–Lyfe Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Lyfe Capital 2019-08-28
HiFiBio–Sequoia Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Sequoia Capital China 2019-08-28
HiFiBio–SEVERAL: investment, 201908 financing round Series C $67m led by new investor IDG Capital 2019-08-28
HiFiBio–VI Ventures: investment, 201908 financing round Series C totalling $67m incl existing + co-investor VI Ventures 2019-08-28
Blue Heron–Eurofins: investment, 201908 acquisition of Blue Heron Biotech by Eurofins Genomics LLC 2019-08-06
Alizé Pharma–SEVERAL: investment, 201907 financing round Series A €67m of Alizé Pharma 3 led by LSP 2019-07-31
Twist Bioscience–Imagene: nucleic acid storage technology, 201907– supply service DNA encapsulation using DNAshell technology 2019-07-25
Infarco–Keensight Capital: investment, 201907 acquisition of Infarco’s majority stake in 3P Biopharmaceuticals by Keensight 2019-07-23
Medicxi Ventures–JnJ: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Medicxi Ventures–Novartis: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Medicxi Ventures–SEVERAL: investment, 201907 closing €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
BiomX–SEVERAL: investment, 201907–201910 listing at NYSE via SPAC merger with $60m in trust account 2019-07-17
Pyxis Oncology–SEVERAL: investment, 201907 financing round Series A $22m led by Leaps by Bayer 2019-07-17
AM-Pharma–SEVERAL: investment, 201907 financing round €116m co-led by LSP + Andera Partners 2019-07-16
BPCE–Illumina: business services, 201907– collab Illumina Accelerator UK + Seventure Partners to provide funding + lab services + coaching to startups 2019-07-16
Sofinnova–Illumina: business services, 201907– collab Illumina Accelerator UK to provide funding + lab services + coaching to startups 2019-07-16
Genmab–Blink Biomedical: therapeutic antibodies, 201907– license to use CD47 Abs in DuoBodies $2.25m upfront + up to $200m per product plus royalties 2019-07-12
Microphyt–CEA Industrie: investment, 201907 financing round totalling €28.5m incl existing + co-investor Supernova Invest 2019-07-11
Microphyt–Demeter: investment, 201907 financing round totalling €28.5m incl existing + co-investor Demeter Partners 2019-07-11
Microphyt–France (govt): investment, 201907 financing round totalling €28.5m incl new + co-lead investor Bpifrance SPI Fund 2019-07-11
Microphyt–Irdi Soridec: investment, 201907 financing round totalling €28.5m incl existing + co-investor Irdi Soridec 2019-07-11
Microphyt–iXO Private Equity: investment, 201907 financing round totalling €28.5m incl new + co-investor iXO Private Equity 2019-07-11
Microphyt–Safilaro: investment, 201907 financing round totalling €28.5m incl new + co-investor Sofilaro 2019-07-11
Microphyt–SEVERAL: investment, 201907 financing round €28.5m co-led by Sofinnova Partners + Bpifrance SPI Fund 2019-07-11
Microphyt–Sofinnova: investment, 201907 financing round totalling €28.5m incl new + co-lead investor Sofinnova Partners 2019-07-11
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

» top